User:Mr. Ibrahem/Alpelisib

Alpelisib, sold under the brand name Piqray, is a chemotherapy medication used to treat certain types of breast cancer. It is used together with fulvestrant. It results in about an extra 5 months of life without the disease getting worse. It is taken by mouth.

Common side effects include high blood sugar, kidney problems, diarrhea, rash, low blood cells, liver problems, pancreatitis, vomiting, and hair loss. Other side effects may include anaphylaxis, infertility, and pneumonitis. Use during pregnancy may harm the baby. It is an alpha-specific PI3K inhibitor.

Alpelisib was approved for medical use in the United States in 2019 and Europe in 2020. In the United States a month of medication costs about 17,000 USD as of 2021.